Skip Navigation



British Medical Bulletin Advance Access published online on August 27, 2008
British Medical Bulletin, doi:10.1093/bmb/ldn031
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
87/1/17    most recent
ldn031v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Zhang, H.
Right arrow Articles by Parkes, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, H.
Right arrow Articles by Parkes, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Genetics of inflammatory bowel disease: clues to pathogenesis

Hu Zhang, Dunecan Massey, Mark Tremelling and Miles Parkes*

IBD Research Group, Andenbrooke's Hospital, Cambridge University, UK

* Correspondence to: Dr M. Parkes, IBD Genetics Research Group, Department of Gastroenterology, Box 201A, Addenbrooke's Hospital, Cambridge CB2 0QQ, UK. E-mail: miles.parkes{at}addenbrookes.nhs.uk

Introduction or background: It has long been recognized from epidemiological data that inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), have a strong genetic predisposition, interacting with unknown environmental drivers to render susceptible individuals at risk for relapsing intestinal inflammation. Substantial progress has been made in the last 2 years in characterizing the susceptibility genes involved.

Sources of data: The recent acceleration in understanding has resulted from the use of new technologies of genome-wide association scanning in large panels of cases and controls.

Areas of agreement: Genome scans have robustly identified 11 susceptibility genes and loci and highlighted a number of new, previously unsuspected pathways as playing an important role in IBD pathogenesis—including the IL23 pathway in IBD overall and specific aspects of innate immunity (particularly NOD2 and the autophagy genes ATG16L1 and IRGM) in CD.

Areas of controversy: The next challenge is to identify specific causal variants at each of the confirmed susceptibility loci and then characterize their biological impact on gene expression and function of the protein product.

Growing points: To date, most attention has focused on CD. A recent meta-analysis has increased the number of confirmed susceptibility loci to 32—more than for any other common disease to date. Attention is now turning to the use of the same techniques in UC to identify new, disease-specific genes and understand areas of overlap.

Areas timely for developing research: This review explores genetic clues to the pathogenesis of IBD derived from the growing list of confirmed IBD susceptibility genes, and briefly elaborates some of the important themes and overlaps that are becoming evident both within IBD and also with other complex diseases.

Keywords: inflammatory bowel disease • genetics • Crohn's • ulcerative colitis • pathogenesis

Accepted for publication July 31, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.